isradipine has been researched along with Complication, Postoperative in 10 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compare the efficacy of isradipine to that of nicardipine for the control of arterial hypertension following coronary artery bypass graft (CABG)." | 9.10 | [Comparison of nicardipine and isradipine in hypertension following coronary artery bypass graft]. ( Achkouty, R; Antakly, MC; Haddad, F; Hayek, G; Khater-Rassi, D; Madi-Jebara, S; Yazigi, A, 2002) |
| "Intravenous isradipine was effective and well tolerated in patients with hypertension after CABG and offers an additional therapeutic option to treat patients after cardiac surgery." | 9.07 | Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. ( Brister, N; Cohen, M; Hines, R; Leslie, J; Levy, JH; Martin, H; Marty, A; Savino, J; Yared, JP, 1994) |
| "In a randomized trial, a calcium antagonist, isradipine (ISR) and sodium nitroprusside (SNP) were compared in the management of hypertension in the early period following coronary artery bypass grafting (CABG)." | 9.07 | Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside. ( David, D; Loria, Y; Ruegg, PC, 1992) |
| "To evaluate the efficacy and duration of action of iv isradipine in the control of postoperative hypertension immediately after myocardial revascularization." | 7.68 | Isradipine for treatment of acute hypertension after myocardial revascularization. ( Alpern, J; Barnette, RE; Brister, NW; McClurken, JB; Schartel, SA, 1991) |
| " Both agents were able to achieve reductions in MAP to 80-90 mmHg quickly and safely, although the effects of isradipine at the dosage used were apparent sooner and gave smoother control than with sodium nitroprusside." | 6.67 | Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery. ( Chan, E; De Lange, S; Lawrence, CJ; Lestrade, A, 1993) |
| "Compare the efficacy of isradipine to that of nicardipine for the control of arterial hypertension following coronary artery bypass graft (CABG)." | 5.10 | [Comparison of nicardipine and isradipine in hypertension following coronary artery bypass graft]. ( Achkouty, R; Antakly, MC; Haddad, F; Hayek, G; Khater-Rassi, D; Madi-Jebara, S; Yazigi, A, 2002) |
| "Intravenous isradipine was effective and well tolerated in patients with hypertension after CABG and offers an additional therapeutic option to treat patients after cardiac surgery." | 5.07 | Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. ( Brister, N; Cohen, M; Hines, R; Leslie, J; Levy, JH; Martin, H; Marty, A; Savino, J; Yared, JP, 1994) |
| "In a randomized trial, a calcium antagonist, isradipine (ISR) and sodium nitroprusside (SNP) were compared in the management of hypertension in the early period following coronary artery bypass grafting (CABG)." | 5.07 | Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside. ( David, D; Loria, Y; Ruegg, PC, 1992) |
| "To evaluate the efficacy and duration of action of iv isradipine in the control of postoperative hypertension immediately after myocardial revascularization." | 3.68 | Isradipine for treatment of acute hypertension after myocardial revascularization. ( Alpern, J; Barnette, RE; Brister, NW; McClurken, JB; Schartel, SA, 1991) |
| " Both agents were able to achieve reductions in MAP to 80-90 mmHg quickly and safely, although the effects of isradipine at the dosage used were apparent sooner and gave smoother control than with sodium nitroprusside." | 2.67 | Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery. ( Chan, E; De Lange, S; Lawrence, CJ; Lestrade, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prisant, LM | 1 |
| Spaulding, VC | 1 |
| Brogden, RN | 1 |
| Sorkin, EM | 1 |
| Leslie, J | 1 |
| Brister, N | 1 |
| Levy, JH | 1 |
| Yared, JP | 1 |
| Marty, A | 1 |
| Martin, H | 1 |
| Hines, R | 1 |
| Savino, J | 1 |
| Cohen, M | 1 |
| Marty, J | 1 |
| Lawrence, CJ | 1 |
| Lestrade, A | 1 |
| Chan, E | 1 |
| De Lange, S | 1 |
| van den Dorpel, MA | 1 |
| Zietse, R | 1 |
| Ijzermans, JN | 1 |
| Weimar, W | 1 |
| Madi-Jebara, S | 1 |
| Khater-Rassi, D | 1 |
| Yazigi, A | 1 |
| Haddad, F | 1 |
| Hayek, G | 1 |
| Achkouty, R | 1 |
| Antakly, MC | 1 |
| Ruegg, PC | 1 |
| David, D | 1 |
| Loria, Y | 1 |
| Brister, NW | 1 |
| Barnette, RE | 1 |
| Schartel, SA | 1 |
| McClurken, JB | 1 |
| Alpern, J | 1 |
2 reviews available for isradipine and Complication, Postoperative
| Article | Year |
|---|---|
Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.
Topics: Cardiac Surgical Procedures; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; | 1995 |
Role of isradipine and other antihypertensive agents in the treatment of peri- and postoperative hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Humans; Hyperte | 1993 |
5 trials available for isradipine and Complication, Postoperative
| Article | Year |
|---|---|
Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside.
Topics: Coronary Artery Bypass; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Infusions, | 1994 |
Comparative study of isradipine and sodium nitroprusside in the control of hypertension in patients following coronary artery-bypass surgery.
Topics: Adolescent; Adult; Aged; Coronary Artery Bypass; Female; Hemodynamics; Humans; Hypertension; Infusio | 1993 |
Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial.
Topics: Adult; Antilymphocyte Serum; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Double-Blind Me | 1994 |
[Comparison of nicardipine and isradipine in hypertension following coronary artery bypass graft].
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Coronary Artery Bypass; Female; Hemodynamic | 2002 |
Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside.
Topics: Adult; Aged; Calcium Channel Blockers; Coronary Artery Bypass; Dihydropyridines; Female; Humans; Hyp | 1992 |
3 other studies available for isradipine and Complication, Postoperative
| Article | Year |
|---|---|
Antihypertensive pharmacobezoar.
Topics: Antihypertensive Agents; Bezoars; Calcium Channel Blockers; Drug Delivery Systems; Gastrointestinal | 2006 |
Update on perioperative hypertension: the place of intravenous isradipine. Proceedings of a workshop. Sonoma, California, October 26, 1991.
Topics: Animals; Humans; Hypertension; Intraoperative Complications; Isradipine; Postoperative Complications | 1993 |
Isradipine for treatment of acute hypertension after myocardial revascularization.
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Coronary Artery Bypass; Female; Hemodynamic | 1991 |